Literature DB >> 25840914

Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells.

Valerie Marsden1, Heather Donaghy2, Kirstie M Bertram1, Andrew N Harman2, Najla Nasr2, Elizabeth Keoshkerian3, Steven Merten4, Andrew R Lloyd3, Anthony L Cunningham5.   

Abstract

Prior HSV-2 infection enhances the acquisition of HIV-1 >3-fold. In genital herpes lesions, the superficial layers of stratified squamous epithelium are disrupted, allowing easier access of HIV-1 to Langerhans cells (LC) in the epidermis and perhaps even dendritic cells (DCs) in the outer dermis, as well as to lesion infiltrating activated T lymphocytes and macrophages. Therefore, we examined the effects of coinfection with HIV-1 and HSV-2 on monocyte-derived DCs (MDDC). With simultaneous coinfection, HSV-2 significantly stimulated HIV-1 DNA production 5-fold compared with HIV-1 infection alone. Because <1% of cells were dually infected, this was a field effect. Virus-stripped supernatants from HSV-2-infected MDDCs were shown to enhance HIV-1 infection, as measured by HIV-1-DNA and p24 Ag in MDDCs. Furthermore these supernatants markedly stimulated CCR5 expression on both MDDCs and LCs. TNF-α was by far the most prominent cytokine in the supernatant and also within HSV-2-infected MDDCs. HSV-2 infection of isolated immature epidermal LCs, but not keratinocytes, also produced TNF-α (and low levels of IFN-β). Neutralizing Ab to TNF-α and its receptor, TNF-R1, on MDDCs markedly inhibited the CCR5-stimulating effect of the supernatant. Therefore, these results suggest that HSV-2 infection of DCs in the skin during primary or recurrent genital herpes may enhance HIV-1 infection of adjacent DCs, thus contributing to acquisition of HIV-1 through herpetic lesions.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25840914     DOI: 10.4049/jimmunol.1401706

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

2.  Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.

Authors:  Marla J Keller; Ashley Huber; Lilia Espinoza; Myrna G Serrano; Hardik I Parikh; Gregory A Buck; Jeremy A Gold; Yiqun Wu; Tao Wang; Betsy C Herold
Journal:  J Infect Dis       Date:  2019-07-31       Impact factor: 5.226

Review 3.  Factors Driving the HIV Epidemic in Southern Africa.

Authors:  Lyle R McKinnon; Quarraisha Abdool Karim
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

4.  Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells.

Authors:  Rogelio Valdez; Gabriella Fenkart; Germán G Gornalusse; Lucia Vojtech; Lamar M Fleming; Urvashi Pandey; Sean M Hughes; Claire N Levy; Erin J Dela Cruz; Fernanda L Calienes; Anna C Kirby; Michael F Fialkow; Gretchen M Lentz; Jessica Wagoner; Lichen Jing; David M Koelle; Stephen J Polyak; David N Fredricks; M Juliana McElrath; Anna Wald; Florian Hladik
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

5.  Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women.

Authors:  Laura E Richert-Spuhler; Laura Pattacini; Margot Plews; Elizabeth Irungu; Timothy R Muwonge; Elly Katabira; Nelly Mugo; Adrienne F A Meyers; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

6.  TRPV4 channel is involved in HSV-2 infection in human vaginal epithelial cells through triggering Ca2+ oscillation.

Authors:  Ping Jiang; Song-Shan Li; Xin-Feng Xu; Chan Yang; Chen Cheng; Jin-Shen Wang; Ping-Zheng Zhou; Shu-Wen Liu
Journal:  Acta Pharmacol Sin       Date:  2022-09-23       Impact factor: 7.169

7.  CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms.

Authors:  Emmanuel Cohen; Jammy Mariotton; Flore Rozenberg; Anette Sams; Toin H van Kuppevelt; Nicolas Barry Delongchamps; Marc Zerbib; Morgane Bomsel; Yonatan Ganor
Journal:  Mucosal Immunol       Date:  2022-05-13       Impact factor: 8.701

Review 8.  Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection.

Authors:  Karen F Ross; Mark C Herzberg
Journal:  Microbes Infect       Date:  2016-03-19       Impact factor: 2.700

9.  Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes.

Authors:  Rachel A Botting; Kirstie M Bertram; Heeva Baharlou; Kerrie J Sandgren; James Fletcher; Jake W Rhodes; Hafsa Rana; Toby M Plasto; Xin Maggie Wang; Jake J K Lim; Laith Barnouti; Mark P Kohout; Tim Papadopoulos; Steve Merten; Norman Olbourne; Anthony L Cunningham; Muzlifah Haniffa; Andrew N Harman
Journal:  J Leukoc Biol       Date:  2017-03-07       Impact factor: 4.962

10.  Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study.

Authors:  Cecilia Svanberg; Rada Ellegård; Elisa Crisci; Mohammad Khalid; Ninnie Borendal Wodlin; Maria Svenvik; Sofia Nyström; Kenzie Birse; Adam Burgener; Esaki M Shankar; Marie Larsson
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.